|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_ocn965707438 |
003 |
OCoLC |
005 |
20231120112153.0 |
006 |
m o d |
007 |
cr ||||||||||| |
008 |
161124t20172017ne a ob 001 0 eng d |
040 |
|
|
|a IDEBK
|b eng
|e rda
|e pn
|c IDEBK
|d YDX
|d OPELS
|d N$T
|d EBLCP
|d OCLCQ
|d OCLCF
|d IDEBK
|d OCLCQ
|d OCLCO
|d MERER
|d OCLCO
|d OCLCQ
|d U3W
|d D6H
|d WYU
|d OCLCO
|d OCLCA
|d OCLCQ
|d S2H
|d OCLCO
|d VT2
|d OCLCO
|d OCLCQ
|d OCLCO
|
016 |
7 |
|
|a 101701438
|2 DNLM
|
019 |
|
|
|a 962834581
|a 963581021
|a 964550951
|a 1066467135
|a 1235843922
|
020 |
|
|
|a 0081006047
|q (ebk)
|
020 |
|
|
|a 9780081006047
|
020 |
|
|
|z 0081006039
|
020 |
|
|
|z 9780081006030
|
035 |
|
|
|a (OCoLC)965707438
|z (OCoLC)962834581
|z (OCoLC)963581021
|z (OCoLC)964550951
|z (OCoLC)1066467135
|z (OCoLC)1235843922
|
050 |
|
4 |
|a R857.M3
|
060 |
|
4 |
|a 2017 B-586
|
060 |
|
4 |
|a QT 37
|
072 |
|
7 |
|a TEC
|x 059000
|2 bisacsh
|
082 |
0 |
4 |
|a 610.28
|2 23
|
245 |
0 |
0 |
|a Monitoring and evaluation of biomaterials and their performance in vivo /
|c edited by Claude E. Dolman.
|
264 |
|
1 |
|a Amsterdam [Netherlands] :
|b Elsevier,
|c 2017.
|
264 |
|
4 |
|c �2017
|
300 |
|
|
|a 1 online resource (226 pages) :
|b illustrations, tables
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Woodhead Publishing series in biomaterials
|
505 |
0 |
|
|a Front Cover; Monitoring and Evaluation of Biomaterialsand their Performance In Vivo; Related titles; Monitoring and Evaluation of Biomaterials and their Performance In Vivo; Copyright; Contents; List of contributors; One -- Monitoring and evaluationof the mechanical performance of biomaterials in vivo; 1 -- Nanostructured ceramics; 1.1 Introduction; 1.2 Test methods for nanostructured ceramics; 1.2.1 Micro/nanostructural evaluation; 1.3 Nanostructured bioceramics; 1.3.1 Low-temperature chemical bonding; 1.3.2 Why nanostructures in chemically bonded ceramics?
|
505 |
8 |
|
|a 1.3.3 Nanostructures in the Ca aluminate-Ca phosphate system1.4 Application field of nanostructured bioceramics; 1.4.1 Dental applications including coating products; 1.4.2 Orthopedic applications; 1.4.3 Drug delivery carrier applications; 1.5 Conclusion and summary; Acknowledgments; References; 2 -- Monitoring degradation products and metal ions in�vivo; 2.1 Introduction; 2.2 Biodegradable metals: state of the art; 2.2.1 The metals and their alloys; 2.2.2 The temporary functional implants; 2.2.3 The in�vivo degradation; 2.3 In�vivo implantation study of biodegradable metals.
|
505 |
8 |
|
|a 2.4 Current in�vivo techniques for monitoring degradation2.4.1 Radiography; 2.4.2 Ultrasonography; 2.4.3 Microcomputed tomography; 2.4.4 Magnetic resonance imaging; 2.4.5 Blood evaluation; 2.4.6 Histological analysis; 2.5 Proposed new in�vivo monitoring techniques; 2.5.1 Monitoring local changes surrounding an implantation site; 2.5.2 Monitoring systemic changes in body fluid; 2.5.3 Off-clinic point-of-care implant monitoring; 2.6 Conclusion; Acknowledgments; References; two -- Monitoring and evaluationof the biological responseto biomaterials in vivo.
|
505 |
8 |
|
|a 3 -- Imaging biomaterial-associated inflammation3.1 Introduction; 3.2 Near-infrared fluorescence imaging; 3.2.1 Inflammatory cell imaging; 3.2.2 Macromolecular protein imaging; 3.2.3 Small molecule imaging; 3.3 Chemiluminescence imaging; 3.4 Bioluminescence imaging; 3.5 Magnetic resonance imaging; 3.6 Conclusions and future perspectives; References; 4 -- Monitoring fibrous capsule formation; 4.1 Introduction; 4.2 Functions; 4.3 Structure; 4.4 Joint classification; 4.5 Fibrous capsule formation; 4.6 Diameters of single-polymer fibers and tissue response.
|
505 |
8 |
|
|a 4.7 Monitor capsule formation around soft tissue4.7.1 Strain gauges; 4.8 Glucose monitoring in�vivo through fluorescent hydrogel fibers; 4.9 Cellular and molecular composition of fibrous capsules formed around silicone breast implants; 4.10 Capsular contracture after two-stage breast reconstruction; 4.11 Graphene-based biosensor for future perspectives; References; 5 -- Monitoring biomineralization of biomaterials in�vivo; 5.1 Introduction; 5.2 Biomineralization; 5.3 Disruption to the biomineralization process and tissue engineering; 5.4 Biomaterials for the repair of mineralized tissue.
|
504 |
|
|
|a Includes bibliographical references and index.
|
650 |
|
0 |
|a Biomedical materials.
|
650 |
|
0 |
|a Biomedical materials
|x Biocompatibility
|x Testing.
|
650 |
1 |
2 |
|a Biocompatible Materials
|0 (DNLM)D001672
|
650 |
2 |
2 |
|a Materials Testing
|0 (DNLM)D008422
|
650 |
|
6 |
|a Biomat�eriaux.
|0 (CaQQLa)201-0025723
|
650 |
|
7 |
|a TECHNOLOGY & ENGINEERING
|x Biomedical.
|2 bisacsh
|
650 |
|
7 |
|a Biomedical materials
|2 fast
|0 (OCoLC)fst00832586
|
650 |
|
7 |
|a Biomedical materials
|x Biocompatibility
|x Testing
|2 fast
|0 (OCoLC)fst01750560
|
700 |
1 |
|
|a Narayan, Roger,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|t Monitoring and evaluation of biomaterials and their performance in vivo.
|z 0081006039
|z 9780081006030
|w (OCoLC)954224105
|
830 |
|
0 |
|a Woodhead Publishing series in biomaterials.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780081006030
|z Texto completo
|